Travere Therapeutics, Inc. 8-K Filing Insights - February 2025

Here are the key insights extracted from the provided section of the financial report:

Company Information:

Name: Travere Therapeutics, Inc.
CIK Number: 0001438533
Address: 3611 Valley Centre Drive, Suite 300, San Diego, CA 92130
Phone Number: 888-969-7879

SEC Filing:

Form Type: 8-K
Filing Date: February 11, 2025

Ticker and Stock Information:

Common Stock: Par value of $0.0001 per share
Ticker Symbol: TVTX
Exchange: NASDAQ

Reporting Period:

Start Date: February 11, 2025
End Date: February 11, 2025

Entity Registration:

State of Incorporation: Delaware
SEC Registration Number: 001-36257
EIN: 27-4842691

Summary

This section indicates that Travere Therapeutics, Inc. filed an 8-K report with the SEC on February 11, 2025, disclosing pertinent information related to its operations or financial status on the same date. The company’s common stock is traded on NASDAQ under the ticker symbol TVTX.